Regulations.gov document
Determination That PEPCID (Famotidine) Tablet, 20 Milligrams and 40 Milligrams, Was Not…
Notice · FDA-2021-P-0885 · posted Jan 18, 2022
Key facts
| Document ID | FDA-2021-P-0885-0005 |
|---|---|
| Title | Determination That PEPCID (Famotidine) Tablet, 20 Milligrams and 40 Milligrams, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness |
| Document type | Notice |
| Subtype | Determinations |
| Agency | FDA |
| Docket | FDA-2021-P-0885 |
| Posted | Jan 18, 2022 |
| Federal Register citation | 87 FR 2616 |
| FR document number | 2022-00832 |
| Comment period opens | Jan 18, 2022 |
| Effective date | Jan 18, 2022 |
At a glance
- 1–9 Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: